This research advances hybrid soft-rigid robot simulations, achieving up to 1000 times faster computations through analytical derivatives in the GVS framework.

Abstract: In this work, we present a contribution on the applicability of the recursive least squares method used for the parametric identification of a corona discharge phenomenon at small distances.

Overview: Strong knowledge of data structures and recognizing common patterns makes complex coding questions easier and faster to solve.Thinking out loud during ...

By now, ChatGPT, Claude, and other large language models have accumulated so much human knowledge that they're far from simple answer-generators; they can also express abstract concepts, such as ...

It’s more than just code. Scientists have found a way to "dial" the hidden personalities of AI, from conspiracy theorists to ...

A team of researchers has found a way to steer the output of large language models by manipulating specific concepts inside ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...